165 related articles for article (PubMed ID: 38105550)
1. Omega-3 fatty acids and cardiovascular prevention: is the jury still out?
Hamilton-Craig C; Kostner K; Colquhoun D; Nicholls SJ
Intern Med J; 2023 Dec; 53(12):2330-2335. PubMed ID: 38105550
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
5. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
[TBL] [Abstract][Full Text] [Related]
6. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
Welty FK; Daher R; Garelnabi M
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
[TBL] [Abstract][Full Text] [Related]
7. Indications for omega-3 fatty acid supplementation in prevention of cardiovascular disease: From fish to pharmaceuticals.
Bosomworth NJ
Can Fam Physician; 2023 Jul; 69(7):459-468. PubMed ID: 37452000
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Kwak SM; Myung SK; Lee YJ; Seo HG;
Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
[TBL] [Abstract][Full Text] [Related]
9. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; PorfĂrio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Yokoyama Y; Kuno T; Morita SX; Slipczuk L; Takagi H; Briasoulis A; Latib A; Bangalore S; Heffron SP
J Cardiol; 2022 Nov; 80(5):416-422. PubMed ID: 35914996
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Marik PE; Varon J
Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
Harris WS; Dayspring TD; Moran TJ
Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
[TBL] [Abstract][Full Text] [Related]
14. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.
Djuricic I; Calder PC
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():383-406. PubMed ID: 36662586
[TBL] [Abstract][Full Text] [Related]
15. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
Rupp H
Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
[TBL] [Abstract][Full Text] [Related]
16. Fish Oil Supplements for Prevention of Cardiovascular Disease: The Jury Is Still Out: CON: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease.
Khoukaz HB; Fay WP
Mo Med; 2021; 118(3):219-225. PubMed ID: 34149081
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model.
Mills JD; Bailes JE; Sedney CL; Hutchins H; Sears B
J Neurosurg; 2011 Jan; 114(1):77-84. PubMed ID: 20635852
[TBL] [Abstract][Full Text] [Related]
18. An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention.
Castellanos-Perilla N; Borda MG; Aarsland D; Barreto GE
Expert Rev Neurother; 2024 Mar; 24(3):313-324. PubMed ID: 38379273
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
Wang IE; Yi S; Block RC; Mousa SA
Nutr Res Rev; 2022 Dec; 35(2):295-307. PubMed ID: 34253265
[TBL] [Abstract][Full Text] [Related]
20. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]